Bone morphogenetic proteins (BMPs) promote astrocytic differentiation of cultured subventricular zone stem cells. To determine whether BMPs regulate the astrocytic lineage in vivo, transgenic mice were constructed that overexpress BMP4 under control of the neuron-specific enolase (NSE) promoter. Overexpression of BMP4 was first detectable by Western analysis on embryonic day 16 and persisted into the adult. The overexpression of BMP4 resulted in a remarkable 40% increase in the density of astrocytes in multiple brain regions accompanied by a decrease in the density of oligodendrocytes ranging between 11 and 26%, depending on the brain region and the developmental stage. No changes in neuron numbers or the pattern of myelination were detected, and there were no gross structural abnormalities. Similar phenotypes were observed in three independently derived transgenic lines. Coculture of transgenic neurons with neural progenitor cells significantly enhanced astrocytic lineage commitment by the progenitors; this effect was blocked by the BMP inhibitor Noggin, indicating that the stimulation of astrogliogenesis was due to BMP4 release by the transgenic neurons. These observations suggest that BMP4 directs progenitor cells in vivo to commit to the astrocytic rather than the oligodendroglial lineage. Further, differentiation of radial glial cells into astrocytes was accelerated, suggesting that radial glia were a source of at least some of the supernumerary astrocytes. Therefore, BMPs are likely important mediators of astrocyte development in vivo.
Introduction
All the major cellular elements of the brain are thought to derive from multipotent stem cells located in periventricular generative zones. Although such multipotent progenitors have the capacity to generate both neurons and glia throughout embryonic and postnatal development (Morshead et al., 1994; Reynolds and Weiss, 1992) , lineage commitment in the developing brain is temporally regulated such that neurons are largely generated prenatally, whereas glia are generated perinatally and postnatally (Jacobson, 1991) . Commitment of multipotent cells to glial lineages may involve generation of more restricted progenitor species (glia-committed progenitor cells) that give rise only to astrocytes and oligodendroglia (Ffrench-Constant and Raff, 1986) . Although the mechanisms that specify neural lineage commitment in vivo are largely unknown, studies of cultured stem cells have suggested several candidate molecules that are believed to regulate neural stem cell differentiation (for review, see Kessler et al., 2001) . However, in some cases, the findings in vitro have not been fully substantiated by studies done in vivo. For example, ciliary neurotrophic factor (CNTF) promotes astrocytic differentiation of cultured neural stem cells (Johe et al., 1996; Lillien et al., 1990) . However, overexpression of CNTF in transgenic mice does not alter astrocyte or oligodendroglial lineage commitment, although it activates microglia and increases levels of glial fibrillary acidic protein (GFAP) (Winter et al., 1995) . Thus, while there is substantial evidence indicating an important role in glial development for factors such as CNTF that signal through gp130/LIF␤ receptors (Johe et al., 1996; Lillien et al., 1990; Turnley and Bartlett, 2000) , the precise role for CNTF in vivo remains unclear.
Astrocytic differentiation of multipotent neural stem cells in culture is also stimulated by exposure to bone morphogenetic proteins (BMPs) (Gross et al., 1996) , a group of secreted signaling molecules in the transforming growth factor-␤ (TGF-␤) superfamily (Hogan, 1996) . Oligodendroglial differentiation of cultured multipotent cells is actively suppressed by the BMPs concomitant with the stimulation of astrocytic differentiation (Gross et al., 1996) . Further, exposure of bipotent glial progenitor cells to BMPs both enhances astrocytic commitment and suppresses oligodendroglial differentiation (Mabie et al., 1997) . Since BMP receptors and ligands are expressed at appropriate times in developing brain (Gross et al., 1996; Li et al., 1998; Lim et al., 2000; Soderstrom et al., 1996; Zhang et al., 1998) , these observations suggest that BMPs may regulate astrocyte lineage commitment in vivo.
Since knockout of BMP2, BMP4, or their receptors results in very early embryonic lethality (Beppu et al., 2000; Mishina et al., 1995; Winnier et al., 1995; Zhang and Bradley, 1996) , we chose a strategy of overexpressing BMP4 to examine the role of the BMPs in astrocyte development in vivo. However, the BMPs have different effects on lineage commitment at different stages of embryonic development so that the timing of transgene overexpression is critical. For example, BMPs appear to promote neuronal differentiation of ventricular zone (VZ) progenitor cells (Li et al., 1998; Mabie et al., 1999) , whereas they promote astrocytic lineage commitment by subventricular zone progenitors (Gross et al., 1996) . Since the neuron-specific enolase (NSE) promoter is predominantly active in differentiated neurons (Forss-Petter et al., 1990) , NSE-driven transgene expression occurs after neurogenesis but before gliogenesis. Construction of NSE-BMP4 overexpressors thus allowed examination of the role of BMP4 during the period of gliogenesis. Analysis of these transgenic animals demonstrated not only that BMP4 increases numbers of astrocytes in vivo, but also that it decreases the number of oligodendroglia.
Materials and methods

Generation of NSE-BMP4 transgenic mice
The NSE-BMP4 transgene was constructed by cloning a 1246-bp fragment containing the murine BMP4 cDNA downstream of the rat neuron-specific enolase (Nse) promoter (Forss-Petter et al., 1990 ) and upstream of a SV40 polyadenylation signal. The Nse promoter construct contained the initial, noncoding exon of the rat Nse locus, which increases expression levels (P. Danielson, personal communication). The transgene fragment was isolated and injected into CB6F 1 mouse embryos, and founder animals were identified by Southern blot analysis according to a standard protocol. Three stable lines were obtained, and these were maintained by successive backcrosses to CB6F 1 .
Western blot analysis
Forebrains of embryonic, neonatal, and adult normal and NSE-BMP4 transgenic mice were dissected and homogenized in RIPA buffer. Protein samples were boiled and electrophoresed (30 g per lane) on 13% polyacrylmide gels. Proteins were transferred to Hybond-P membrane (Amersham Life Science, Buckinghamshire, England) in a Mini-Trans-Blot tank transfer apparatus (BioRad, Hercules, CA). Transfer proceeded overnight at 30V. BMP4 protein was detected by using a BMP4-specific monoclonal antibody (Masuhara et al., 1995) at 1:100 dilution, an HRPlinked anti-mouse secondary antibody (1:50,000; Pierce, Rockford, IL), and West Dura Extended luminescent HRP substrate (Pierce).
Tissue processing
Mice were anesthetized with pentobarbital and perfused with normal saline followed by 4% paraformaldehyde in phosphate buffer (0.1 M, pH 7.2). Tissue was dissected, postfixed 4 h at 4°C, infiltrated with 20% sucrose (48 h, 4°C) and frozen. Twelve-micron cryostat sections were thaw-mounted on SuperFrost/Plus slides (Fisher Scientific, Pittsburgh, PA), air-dried, and stored at Ϫ20°C until use. For GFAP immunohistochemistry in adult mice, 80-micron parasagittal vibratome sections were prepared and processed as free-floating sections.
Immunohistochemistry
Sections were incubated overnight at 4°C with primary antibodies diluted in phosphate-buffered saline (PBS) with 0.1% Triton X-100 and 10% normal goat or horse serum as appropriate. Primary antibody dilutions were as follows: monoclonal mouse anti-GFAP 1:500 (Sigma, St. Louis, MD); polyclonal rabbit anti-S100 1:2500 (DAKO, Carpinteria, CA); polyclonal rabbit anti-GFAP 1:1000 (DAKO); monoclonal rat anti-CD11b (Mac-1) 1:100 (Serotec, Oxford, UK); monoclonal mouse anti-RC2 1:2 (Developmental Studies Hybridoma Bank, Iowa City, IA); polyclonal rabbit anti-GST-Yp 1:500 (Biotrin International, Dublin, Ireland); monoclonal anti-CNPase 1:100 (Sigma); and polyclonal goat anti-BMP4 1:100 (Reseach Diagnostics, Flanders, NJ). Primary antibodies were detected with either biotin-labeled secondary antibodies (Vector Laboratories, Burlingame, CA) followed by the ABC Elite biotin detection system (Vector Laboratories) or secondary antibodies labeled with Alexa 488 or 546 flurophores (Molecular Probes, Eugene, OR).
Cell counts
Astrocyte, oligodendrocyte, and total cell density were determined within a region of primary somatosensory cortex extending from approximately bregma Ϫ0.94 mm to bregma Ϫ1.62 mm (Franklin, 1997) . Coronal sections from within this region, obtained from postnatal day 30 NBMP4 transgenic and wild-type brains, were processed for anti-S100 or anti-GST-Yp immunohistochemistry with a green fluorescent Alexa-488 secondary antibody (Molecular Probes) and counterstained with the blue fluorescent nucleophilic dye 4Ј,6-diamidino-2-phenylindole (DAPI). Fluorescent staining was visualized with an Olympus BX51 epifluorescence microscope (Olympus America, Melville, NY) equipped with a SpotRT digital camera (Diagnostic Instruments, Sterling Heights, MI) connected to an Apple Macintosh computer (Apple Computer, Cupertino, CA). A 20ϫ magnification objective lens was used. For each section, the 0.2-mm 2 viewing frame of the SpotRT camera was placed within the infragranular layers of somatosensory gray matter. The resulting green and blue fluorescent images were recorded and digitally superimposed by using Adobe Photoshop image analysis software. A blinded observer counted total DAPI-stained nuclei within each section as well as the number of S100ϩ or GST-Ypϩ cells. A minimum of 11 (for GST-Yp) or 5 (for S100) sections from each of 4 transgenic and 4 wild-type mice were analyzed. Data are presented as mean cell number per 0.2-mm 2 window ϩ/Ϫ SEM with P values calculated by the two-tailed t test. Oligodendrocyte density was also determined in the centrum semiovale of PN10 and adult brains at a depth of 1 mm (PN10) or 2 mm (adult) from the cortical border at the central sulcus by using CNPase immunohistochemistry and similar techniques. Four sections from each of 5 transgenic and 5 wild-type mice were analyzed for CNPase staining.
Cell culture
Hippocampus was dissected from PN18 transgenic or wildtype embryos, incubated in trypsin 0.01% for 10 min, and titurated to dissociate the cells. The cells were passed through a 45-m Nitex filter and plated at a density of 5 ϫ 10 5 cells per well (Falcon 6-well plate) on a laminin substrate in B27-supplemented neurobasal medium (Invitrogen). Independent cultures were established for each embryo, and genotyping was performed at the conclusion of the culture study. Control wells received no cells. After 48 h of culture of the wells in a 5% CO 2 incubator, E18 multipotent progenitor cells from wildtype animals cultured as neurospheres (Gross et al., 1996) were plated onto laminin-coated membranes of BD Falcon inserts, and the inserts were placed into the wells. Some wells were treated with 1 g/ml of Noggin (Regeneron) at the time of coculture with the progenitor cells. After 96 h of coculture, astrocytic lineage commitment by the progenitor cells was assessed by using previously described techniques (Mabie et al., 1999) . In an additional set of wells, progenitor cells were treated with BMP4 (20 ng/ml) for comparison.
Results
Generation of NSE-BMP4 transgenic mice
Three independent NSE-BMP4 founder animals were identified by Southern blot analysis (Fig. 1A) , and stable lines were established for all three. Despite differences in transgene copy number, levels of BMP4 mRNA were comparable in all three lines. The results presented below are largely derived from line 3, but lines 1 and 2 displayed a similar phenotype (see Fig. 3 ). RT-PCR analysis demonstrates expression of the transgene in adult NSE-BMP4 brain (Fig. 1B) . The increase in BMP4 expression was first detectable by Western blot analyses at embryonic day 16 (Fig. 1C) , and the increase persisted into adult life. No increase in BMP4 expression was detected outside of the nervous system (data not shown). Gross brain anatomy appeared normal in NBMP4 transgenic mice and brain weights did not differ (data not shown).
Astrocyte differentiation is augmented in NSE-BMP4 mice
BMP treatment of cultured SVZ progenitor cells results in commitment of the cells to the astrocyte lineage (Gross et al., 1996) . To define the effects of BMP4 overexpression on astrocyte differentiation in vivo, expression of the astrocyte marker, glial fibrillary acidic protein (GFAP), was examined in adult wild-type and transgenic brains. There was a widespread increase in the number of GFAP ϩ astrocytes in multiple brain regions in transgenic mice. The increase in the number of GFAP ϩ cells was most prominent in the neocortex , where normally few GFAP ϩ cells are found during adulthood (Kalman and Hajos, 1989) . Supernumerary GFAP ϩ astrocytes in the adult NSE-BMP4 neocortex were consistently clustered in the infragranular layers (Fig. 2B ). Increased numbers of GFAP ϩ cells were also observed in hippocampus and striatum ( Fig. 2G-J ) and in the hindbrain (Fig. 3E-G) . While the density of GFAP ϩ astrocytes was clearly increased in NSE-BMP4 mice, the supernumerary astrocytes were similar in size and shape to those present in wild-type mice ( Fig. 2E and F) . Myelin morphology assessed by silver stain (see Fig. 6 ) and CNPase immunohistochemistry (Sheedlo and Sprinkle, 1983 ) and neuronal morphology assessed by Nissl (see Fig. 6 ) and Golgi stains were not altered in transgenic brains. Moreover, there was no significant change in overall brain weight.
Quantitative alterations in astrocyte numbers in NSE-BMP4 mice
The number of GFAP ϩ astrocytes was dramatically increased in NSE-BMP4 mice. However, not all astrocytes in the normal brain are immunoreactive for GFAP (Ludwin et al., 1976) , and it was unclear whether the additional GFAP ϩ astrocytes reflected an increase in absolute astrocyte numbers or merely augmented GFAP expression in the normal complement of astrocytes. This issue was addressed by quantitating the total density of astrocytes in neocortical gray matter using an independent astrocyte marker, S-100 (Ludwin et al., 1976) . There was a 39.7% increase (n ϭ 4; P Ͻ 0.001) in S100ϩ astrocytes in NSE-BMP4 transgenic mice compared with wild-type littermates (Fig. 4E) . Similar increases were observed with another astrocyte marker, the Y b subunit of glutathione-S-transferase (GST-Y b ) (Cammer et al., 1989 ) (data not shown). These results demonstrate that the density of astrocytes is increased in NSE-BMP4 mice independent of any changes in GFAP expression.
Oligodendrocyte numbers are decreased in NSE-BMP4 mice
The density of oligodendrocytes in the same area of adult neocortex was quantitated by using an oligodendrocytespecific marker, the Y p subunit of glutathione-S-transferase (GST-Y p ) (Tansey and Cammer, 1991) . Remarkably, the density of GST-YPϩ oligodendrocytes was decreased by 11.3% (n ϭ 4; P Ͻ 0.02) in NSE-BMP4 transgenic mice compared with littermates (Fig. 4E) . A similar decrease in oligodendrocytes in adult neocortex was observed by using CNPase immunocytochemistry, and oligodendrocyte numbers were also quantitated in other areas of the brain by using CNPaseϩ immunocytochemistry. There was a 26% decrease (n ϭ 5; P Ͻ 0.01) in the number of oligodendrocytes in the centrum semiovale of postnatal day 10 transgenic animals ( Fig. 4F ). In the adult animal, there was a 16.7% decrease (n ϭ 5; P Ͻ 0.02) in the same area, suggesting some compensation in the adult animal. In the perihippocampal white matter of the adult animal, there was a 19.3% reduction (n ϭ 4; P Ͻ 0.02) in oligodendrocyte number. Thus, NSE-BMP4 transgenic mice displayed both increased astrocyte density and decreased oligodendrocyte density.
BMP release mediates the effects of transgenic neurons on astrogliogenesis in vitro
Do neurons from the NSE-BMP4 mice release BMP4, and does BMP4 release mediate the effects of overexpression of BMP4 on astroglial lineage commitment? To address these issues, neurons from wildtype or transgenic animals were cocultured across a permeable membrane with neural progenitor cells, and some of the cultures were treated with the BMP inhibitor Noggin (Fig. 5) . Independent neuronal cultures were established for each embryo, and genotyping was performed at the conclusion of the culture study. Approximately 40% of the progenitor cells differentiated into GFAP-immunoreactive astrocytes in the absence of coculture with neurons. However, more than 80% of the cells committed to the astrocytic lineage when cocultured with neurons from the NSE-BMP4 mice, comparable to the effects of adding exogenous BMP4 (which alone is sufficient to induce astrocyte lineage commitment; Gross et al., 1996) . Addition of Noggin to the culture medium completely prevented this increase in astrogliogenesis in the cocultures, suggesting that BMP4 release by neurons from the NSE-BMP4 mice was necessary and sufficient for the effects on astrocytic differentiation. By contrast, coculture of progenitor cells with wildtype neurons did not significantly alter astrocytic lineage commitment.
Lack of reactive gliosis in NSE-BMP4 mice
Inflammatory processes in the brain trigger increased GFAP immunoreactivity, activation of microglia, and alterations in astrocyte morphology. Collectively, these changes are referred to as reactive gliosis. Ciliary neurotrophic factor (CNTF), which promotes astrocyte differentiation of neural progenitor cells in culture, did not increase astrocytes numbers when overexpressed in vivo but did induce reactive gliosis (Winter et al., 1995) . We therefore considered whether BMP4 might also induce reactive gliosis. As previously mentioned, however, there were no overt changes in astrocyte size or morphology in NSE-BMP4 mice ( Fig. 2E  and F) . Nevertheless, microglial activation was examined in NSE-BMP4 mice by using the microglial marker, Mac-1 (Perry et al., 1985) (Fig. 6A-D) . Mac-1 ϩ microglia were observed in both wild type and NSE-BMP4 mice. No change in number, morphology, or staining intensity of Mac-1 ϩ cells was observed, suggesting that microglia were not activated in the NSE-BMP4 mice. Thus, unlike CNTF, BMP4 does not induce reactive gliosis when overexpressed in vivo.
Timing of astrocyte maturation in NSE-BMP4 mice
The developmental progression of astrocyte differentiation was compared in wild-type and NSE-BMP4 transgenic mice. Since the timing of astrocyte differentiation varies considerably among brain regions, these experiments addressed the dorsal neocortex as a representative region. Using GFAP immunohistochemistry to identify astrocytes, the earliest differences in NSE-BMP4 mice were found on postnatal day 6 (P6) (Fig. 7A and B) . At this age, weakly stained GFAP ϩ radial fibers, presumably the apical processes of radial glia, were present in both wild-type and NSE-BMP4 neocortex. However, transgenic neocortex also contained occasional GFAP ϩ astrocytes (Fig. 5B ), whereas such cells were not observed in P6 wild-type brains (Fig.  7A) . By postnatal day 7 (P7), GFAP ϩ astrocytes were found in normal mice, but were far more numerous in transgenic mice ( Fig. 7C and D) . Thus, the appearance of GFAP ϩ astrocytes was accelerated by approximately 1 day in NSE-BMP4 transgenic neocortex compared with wild-type.
Radial glia conversion to astrocytes is enhanced in NSE-BMP4 mice
Radial glia are specialized cells found in embryonic and neonatal vertebrate brains. Their nuclei reside in the periventricular zones, but they possess long apical processes which extend through the developing neuronal layers (i.e., the cortical plate) and terminate at the pial surface (ChanasSacre et al., 2000) . In mammals, radial glia disappear after birth, and their disappearance occurs in part through conversion into astrocytes (Choi and Lapham, 1978; Misson et al., 1991; Schmechel and Rakic, 1979; Voigt, 1989) . The P6 -P7 period, when astrocyte numbers begin to increase in transgenic mice, falls within the period when murine radial glia are known to convert into astrocytes (Misson et al., 1988) . The conversion of murine radial glial cells into astrocytes is accompanied by loss of a radial glia-specific antigen recognized by the monoclonal antibody RC-2 (Misson et al., 1988), as well as by upregulation of GFAP. To test the hypothesis that prematurely differentiated GFAP ϩ astrocytes in NSE-BMP4 neocortex may have arisen, in part, from radial glia, RC-2 and GFAP immunostaining were examined in P6 NSE-BMP4 brains. The majority of prematurely differentiated GFAP ϩ cells in P6 NSE-BMP4 neocortex (Fig. 8A ) also labeled with RC-2 antibody ( Fig.  8B and C) . RC-2 immunoreactivity is not normally observed in mature astrocytes (Misson et al., 1988) , and at later developmental stages, no RC-2ϩ astrocytes were detectable in either wild-type or NSE-BMP4 mice (data not shown). Although the number of such cells that were detectable in a single brain section was not large, the expression of the RC-2 antigen by GFAP ϩ astrocytes found prematurely in P6 NSE-BMP4 neocortex suggests that these cells may be radial glia converting to astrocytes. BMP4 therefore appears to accelerate the differentiation of some radial glia, and it is likely that at least some of the supernumerary astrocytes observed in adult NSE-BMP4 transgenic brains are derived from radial glia. Fig. 4 . Quantitation of glial cell numbers in NSE-BMP4 and wild-type neocortex. Representative fields showing S100 ϩ astrocytes (A, B) and GST-Ypϩ oligodendrocytes (C, D) from NSE-BMP4 transgenic (B, D) and wild-type (A, C) neocortices are shown. Astrocyte density is dramatically increased, while oligodendrocyte density is diminished (E). (n ϭ 4; *, P Ͻ 0.001; **, P Ͻ 0.02). Oligodendrocyte density was also assessed in other areas of brain, including centrum semiovale of PN10 (n ϭ 5; **, P Ͻ 0.01) and adult (n ϭ 5; ***, P Ͻ 0.02) mice and perihippocampal white matter (n ϭ 4; ***, P Ͻ 0.02) of adult mice using CNPase immunohistochemistry (F). Fig. 5 . Release of BMP mediates effects of neurons from NSE-BMP4 mice on astrocytic lineage commitment of cocultured progenitor cells. Neurons were cultured from E18 transgenic (NBMP4) and wildtype embryos. Control dishes received no neurons (None). After 48 h, noggin was added to half of the dishes, and inserts containing cultured progenitor cells were placed into the wells with a semipermeable separating the neurons and the progenitor cells. In an additional set of wells, the progenitor cells were plated into the inserts without cocultured neurons but in the presence of BMP4 (20 ng/ml). Four days thereafter, the commitment of the progenitors to the astrocytic phenotype was assessed by using GFAP immunocytochemistry. Genotyping of the animals was performed after completion of the experiment. n ϭ 8 for wildtype/Ϫnoggin group; n ϭ 6 for the wildtype/ ϩnoggin group; n ϭ 5 for NBMP4/Ϫnoggin; n ϭ 7 for nBMP4/ϩnoggin; n ϭ 8 for None/Ϫnoggin; n ϭ 8 for None/ϩnoggin; n ϭ 8 for BMP4 group. *, Differs from all other groups except BMP4 at P Ͻ 0.01 by ANOVA.
Discussion
Since BMP4 directs astrocytic differentiation of SVZ progenitor cells in vitro (Gross et al., 1996) , we sought to determine whether the factor similarly induces astrocyte lineage commitment in vivo. However, knockout of BMP4 or its receptors results in very early embryonic lethality (Beppu et al., 2000; Mishina et al., 1995; Winnier et al., 1995; Zhang and Bradley, 1996) . Therefore, we chose a strategy of overexpressing BMP4 to define its effects in vivo. The timing of expression of the transgene was critical for these studies since the BMPs regulate many aspects of early neural development. Inhibition of BMP signaling initiates formation of the neural tube (Hemmati-Brivanlou and Melton, 1997), while reinstitution of BMP signaling in the neural tube induces neural crest formation (Liem et al., 1995; Mujtaba et al., 1998) . Further, BMP signaling in VZ progenitor cells promotes either neuronal differentiation or apoptosis (Li et al., 1998; Mabie et al., 1999) . This suggests that overexpression of the factor during early embryogenesis would alter some of these other functions and might fatally perturb neural development. For these reasons, we overexpressed BMP4 under the control of the NSE promoter, which is predominantly active in differentiated neurons (Forss-Petter et al., 1990) . BMP4 levels did not increase until E16, which is late for an effect on neurogeneisis or dorsal-ventral specification but appropriate for an effect on gliogenesis. Overexpression peaked during the first several postnatal weeks, although overexpression persisted even in the adult. This allowed examination of the effects of BMP4 during the period of gliogenesis in the brain.
There was a 40% increase in neocortical astrocyte density in the brains of adult NSE-BMP4 mice accompanied by an 11-19% decrease in oligodendrocyte density, depending on the region of the brain sampled. This suggests that a portion of the increase in astrocyte density may occur through diversion of glial precursors from the oligodendrocyte lineage, similar to our prior tissue culture observations (Gross et al., 1996; Mabie et al., 1997) . The increase in astrocyte number is numerically greater, however, than the decrease in oligodendrocyte number ( Fig. 4E and F) . This discrepancy may indicate that BMP4 affects multiple progenitor cell types, only some of which would otherwise become oligodendrocytes. It is also possible, however, that oligodendrocyte numbers are normalized by feedback regulation of oligodendrocyte survival or proliferation. A feedback mechanism is known to operate in the spinal cord, where gross modifications in initial oligodendrocyte precursor numbers are corrected, leaving the final oligodendrocyte number unchanged (Calver et al., 1998) . In fact, the density of oligodendroglia in the centrum semiovale was decreased by 26% at PN 10 but only by 17% in the adult, suggesting that such compensation may have occurred in the NSE-BMP4 mice.
GFAP-immunoreactive astrocytes were observed in NSE-BMP4 transgenic neocortex on P6, 1 day earlier than in wild-type mice. Some of these astrocytes were also immunopositive for the radial glial marker RC-2, suggesting that they are intermediate forms in the conversion of radial glia into astrocytes. Thus, it appears that BMP4 may have promoted accelerated differentiation of radial glia. Radial glia are classically described as a transient cell type that is ultimately committed to astrocyte differentiation, and in this respect, transgenic overexpression of BMP4 may simply accelerate one normal pathway for astrocyte differentiation. However, recent studies suggest that radial glia may, in fact, be multipotent neural progenitor cells (Alvarez-Buylla et al., 2001; Parnavelas and Nadarajah, 2001) . Radial glial cultures from embryonic and neonatal mice are capable of generating neural progenitor cells (Hartfuss et al., 2001; Laywell et al., 2000) similar to those used for our initial studies of BMP-directed differentiation. Further, radial glia give rise to neurons during early neurogenesis (Alvarez-Buylla et al., 1990; Malatesta et al., 2000; Miyata et al., 2001; Noctor et al., 2001 ) and perhaps to oligodendrocytes as well as astrocytes later in development (Choi and Kim, 1985; Hirano and Goldman, 1988) . This raises the possibility that accelerated radial glial differentiation to astrocytes in NSE-BMP4 mice represents the premature maturation of progenitor cells that would otherwise have continued to divide and eventually produce oligodendrocytes. This mechanism could, in itself, account for some of the reduction in final oligodendrocyte density observed in NSE-BMP4 transgenic neocortex. However, the size of the numerical increase in astrocyte numbers is probably too large for this single mechanism to fully account for the changes.
BMP receptors and ligands are expressed at appropriate times in developing brain (Gross et al., 1996; Li et al., 1998; Lim et al., 2000; Soderstrom et al., 1996; Zhang et al., 1998) to regulate astrocyte lineage commitment by subventricular zone progenitor cells. BMP receptors are abundant in the periventricular generative zones throughout the period of gliogenesis (Zhang et al., 1998) . BMP4 and BMP2, which both promote astrocyte lineage commitment by cultured progenitor cells, are particularly abundant in the developing brain (Gross et al., 1996; Li et al., 1998; Lim et al., 2000) . The BMPs appear to be expressed both by progenitor cells and by developing neurons (Gross et al., 1996; Li et al., 1998; Lim et al., 2000) , suggesting a model in which BMP produced both by progenitors and by newly formed neurons stimulates astrocyte lineage commitment. In this model, newly formed neurons that migrate tangentially along radial glia might induce astrocytic differentiation of the radial glial cell, while neuroblasts in the VZ/SVZ induce astrocytic differentiation of surrounding progenitor cells. This dual mechanism would help to explain the premature and increased differentiation of radial glial into astrocytes in the NSE-BMP4 transgenic animals as well as the size of the increase in the number of astrocytes.
Overexpression of BMP4 in the NSE-BMP4 mice did not alter neuronal density or morphology as determined by Nissl (Fig. 6) and Golgi staining. Thus, no apparent effect on neurogenesis was observed at the level of resolution employed in this study. Nevertheless, it is possible that BMP4 overexpression may have produced unrecognized changes in any of a number of neuronal phenotypic traits and that such changes in neuronal development could secondarily have influenced astrocyte numbers. However, the proastrocytic effects on cocultured progenitor cells of neurons from the NSE-BMP4 mice were completely blocked by Noggin, indicating that the transgenic neurons release BMP4 and that this release is necessary for the effects on astrocytic lineage commitment. BMP4 promotes rapid exit from cell cycle of both neural progenitor cells and of glially committed progenitor cells (Mabie et al., 1997 (Mabie et al., , 1999 and it has no effect on proliferation or survival of mature astrocytes, so the increase in astrocyte numbers is unlikely to reflect selective proliferation of cells in the astrocytic lineage. It is possible that BMP4 also exerted some effects on progenitor cell migration. However, analysis of immunocytochemistry for NG-2, a marker for one type of migratory glial precursor cell, did not show any demonstrable difference in migration patterns in the transgenic animals (data not shown). Nevertheless, although these findings coupled with prior studies in vitro (Gross et al., 1996; Mabie et al., 1997) strongly suggest that BMP4 promotes astrocytic lineage commitment, effects on proliferation, differentiation, and/or survival of cells in the astrocytic lineage cannot be excluded.
Previous studies showed that CNTF promotes astrocyte differentiation and GFAP expression both in tissue culture and in vivo (Hudgins and Levison, 1998; Hughes et al., 1988; Johe et al., 1996; Winter et al., 1995) . Similar results are obtained with the related cytokine interleukin-6 (IL-6) (Fattori et al., 1995) . The presence of activated microglia in transgenic lines that overexpress CNTF, or IL-6, together with morphologic features of the transgenic astrocytes indicate that these ligands induce a reactive gliosis similar to that seen following brain injury (Chiang et al., 1994; Fattori et al., 1995; Winter et al., 1995) . In contrast to CNTF and IL-6 transgenic mice, we find that overexpression of BMP4 in the NSE-BMP4 transgenic mice does not induce reactive gliosis. Nevertheless, it is interesting to note that BMP receptors are expressed by neurons after mechanical brain injury (Lewen et al., 1997) and that BMP-6 is released by neurons upon ischemic injury (Martinez et al., 2001) . BMPs may therefore play a role in brain injury responses and could be responsible for some of the astrocyte differentiation observed after injury.
In the wild-type mouse brain, many astrocytes are not GFAP-immunoreactive (Ling and Leblond, 1973) . This is particularly true in the neocortex, where GFAP ϩ astrocytes are relatively rare (Kalman and Hajos, 1989) . Astrocytes induced by BMPs, in contrast, express high levels of GFAP both in tissue culture (Gross et al., 1996) and in NSE-BMP4 mice (Figs. 2 and 3) . The significance of this finding is unclear. Ongoing GFAP expression may simply reflect continuing BMP stimulation. Indeed, BMP4 levels continue to be elevated even in mature NSE-BMP4 mice (Fig. 1C) . Alternatively, differences in GFAP expression may reflect differing lineages of astrocytes. If so, ectopic GFAP ϩ astrocytes in NSE-BMP4 neocortex may represent ectopic differentiation of a distinct astrocyte subtype usually found in regions (including hippocampus, white matter, and entorhinal cortex) where GFAP ϩ astrocytes are common in wild-type mice.
In summary, overexpression of BMP4 increases the number of astrocytes in the brain concomitant with a decrease in the number of oligodendroglia. Further, radial glia conversion to astrocytes is enhanced by BMP4 overexpression. These observations, coupled with prior observations regarding BMP actions in vitro and expression of BMPs and their receptors in developing brain, strongly suggest that BMP signaling plays a central role in astrogliogenesis. Moreover, these studies provide evidence in vivo that the balance between numbers of astrocytes and oligodendroglia is regulated by BMP signaling.
